0001773751-22-000099.txt : 20220317 0001773751-22-000099.hdr.sgml : 20220317 20220317191535 ACCESSION NUMBER: 0001773751-22-000099 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220315 FILED AS OF DATE: 20220317 DATE AS OF CHANGE: 20220317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maltz Jules A. CENTRAL INDEX KEY: 0001553254 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 22750478 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 2, SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 4 1 wf-form4_164755891771303.xml FORM 4 X0306 4 2022-03-15 0 0001773751 Hims & Hers Health, Inc. HIMS 0001553254 Maltz Jules A. 2269 CHESTNUT STREET, #523 SAN FRANCISCO CA 94123 1 0 1 0 Class A Common Stock 2022-03-15 4 M 0 9794 A 19001 D Class A Common Stock 53974 I Held by Institutional Venture Partners XV Executive Fund, L.P. Class A Common Stock 10147758 I Held by Institutional Venture Partners XV, L.P. Class A Common Stock 10201746 I Held by Institutional Venture Partners XVI, L.P. Restricted Stock Unit 2022-03-15 4 M 0 17 0 D Class A Common Stock 17.0 52 D Restricted Stock Unit 2022-03-15 4 M 0 871 0 D Class A Common Stock 871.0 2614 D Restricted Stock Unit 2022-03-15 4 M 0 8906 0 D Class A Common Stock 8906.0 26721 D The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of March 15, 2021. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. /s/ Soleil Boughton, Attorney-in-Fact 2022-03-17